Madison, WI (PRWEB) January 06, 2012
Sciclips, a Madison (WI) based company, has announced the launching of a comprehensive oncology biomarker and companion diagnostic pathway database. S. Kar, Ph.D, the Founder of Sciclips has mentioned in her statement that “With the growing trend of personalized healthcare concept and advancement in biomarker research, there is a need for a comprehensive cancer biomarker database that can help in finding new diagnostic, prognostic and companion diagnostic biomarkers. Future success in developing innovative personalized cancer drugs lies in adopting new differential diagnostic procedures along with companion biomarker assays to identify the most appropriate cancer patient, tumor type and disease state. Our database will be a useful tool for the discovery of new cancer biomarkers as well as clinical validation of biomarkers.”
According to T. Johnson, Ph.D, the Chief Technical Lead - biomarker database development, “Our cancer companion diagnostics biomarker pathway database is an innovative database of protein-protein interactions networks of cancer drug efficacy or predictive biomarkers. We believe this manually curated database will open up new scientific avenues for developing personalized strategies for monitoring cancer progression, treatment, diagnosis and prognosis.”
The statement released by Sciclips has mentioned that their current database contains more than 8700 discovery phase or preclinical or clinical cancer biomarkers that were identified or validated using patient derived samples. The database can be viewed at: http://www.sciclips.com/sciclips/diagnostic-prognostic-cancer-biomarker-main.do
Sciclips (http://www.sciclips.com) is a web-based company that facilitates scientific collaboration and open innovation among scientists and researchers around the world. Sciclips also provides a scientific platform for researchers with most comprehensive information and tools in various research areas such as stem cell, proteomics, biomarkers, metabolomics,drug discovery, malaria and tuberculosis.